Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1981 1
1986 1
1988 2
1989 1
1990 1
1992 3
1993 4
1994 2
1995 8
1996 4
1997 6
1998 4
1999 2
2000 4
2001 6
2002 4
2003 4
2004 6
2005 6
2006 4
2007 10
2008 14
2009 13
2010 15
2011 15
2012 15
2013 10
2014 11
2015 16
2016 23
2017 12
2018 27
2019 21
2020 24
2021 15
2022 25
2023 36
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

343 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for gaffney k
Search for Gafney K instead (2 results)
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials.
van der Heijde D, Deodhar A, Baraliakos X, Brown MA, Dobashi H, Dougados M, Elewaut D, Ellis AM, Fleurinck C, Gaffney K, Gensler LS, Haroon N, Magrey M, Maksymowych WP, Marten A, Massow U, Oortgiesen M, Poddubnyy D, Rudwaleit M, Shepherd-Smith J, Tomita T, Van den Bosch F, Vaux T, Xu H. van der Heijde D, et al. Among authors: gaffney k. Ann Rheum Dis. 2023 Apr;82(4):515-526. doi: 10.1136/ard-2022-223595. Epub 2023 Jan 17. Ann Rheum Dis. 2023. PMID: 36649967 Free PMC article.
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study.
Solomon JJ, Danoff SK, Woodhead FA, Hurwitz S, Maurer R, Glaspole I, Dellaripa PF, Gooptu B, Vassallo R, Cox PG, Flaherty KR, Adamali HI, Gibbons MA, Troy L, Forrest IA, Lasky JA, Spencer LG, Golden J, Scholand MB, Chaudhuri N, Perrella MA, Lynch DA, Chambers DC, Kolb M, Spino C, Raghu G, Goldberg HJ, Rosas IO; TRAIL1 Network Investigators. Solomon JJ, et al. Lancet Respir Med. 2023 Jan;11(1):87-96. doi: 10.1016/S2213-2600(22)00260-0. Epub 2022 Sep 5. Lancet Respir Med. 2023. PMID: 36075242 Clinical Trial.
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis.
Baeten D, Sieper J, Braun J, Baraliakos X, Dougados M, Emery P, Deodhar A, Porter B, Martin R, Andersson M, Mpofu S, Richards HB; MEASURE 1 Study Group; MEASURE 2 Study Group. Baeten D, et al. N Engl J Med. 2015 Dec 24;373(26):2534-48. doi: 10.1056/NEJMoa1505066. N Engl J Med. 2015. PMID: 26699169 Free article. Clinical Trial.
BRITSpA at five.
Keat A, Bennett AN, Gaffney K, Jones GT, Martindale J, Sengupta R, Siebert S, Marzo-Ortega H. Keat A, et al. Among authors: gaffney k. Rheumatology (Oxford). 2020 Apr 1;59(4):699-701. doi: 10.1093/rheumatology/kez523. Rheumatology (Oxford). 2020. PMID: 31710687 Free article. No abstract available.
Smoking in spondyloarthritis: unravelling the complexities.
Zhao SS, Goodson NJ, Robertson S, Gaffney K. Zhao SS, et al. Among authors: gaffney k. Rheumatology (Oxford). 2020 Jul 1;59(7):1472-1481. doi: 10.1093/rheumatology/keaa093. Rheumatology (Oxford). 2020. PMID: 32236486 Review.
Treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope.
Zhao SS, Harrison SR, Chan A, Clarke N, Davis C, Eddison J, Gregory WJ, Jones GT, Marzo-Ortega H, Murphy DJ, Sandhu V, Sengupta R, Siebert S, Thompson B, Webb D, Yates M, Gaffney K. Zhao SS, et al. Among authors: gaffney k. Rheumatol Adv Pract. 2023 May 15;7(2):rkad039. doi: 10.1093/rap/rkad039. eCollection 2023. Rheumatol Adv Pract. 2023. PMID: 37197377 Free PMC article. Review.
Chronic periaortitis.
Jois RN, Gaffney K, Marshall T, Scott DG. Jois RN, et al. Among authors: gaffney k. Rheumatology (Oxford). 2004 Nov;43(11):1441-6. doi: 10.1093/rheumatology/keh326. Epub 2004 Jul 20. Rheumatology (Oxford). 2004. PMID: 15266064
Comparative Efficacy of Biologic Disease-Modifying Anti-Rheumatic Drugs for Non-Radiographic Axial Spondyloarthritis: A Systematic Literature Review and Bucher Indirect Comparisons.
Akkoç N, Arteaga CH, Auteri SE, Betts M, Fahrbach K, Kim M, Kiri S, Neupane B, Gaffney K, Mease PJ. Akkoç N, et al. Among authors: gaffney k. Rheumatol Ther. 2023 Apr;10(2):307-327. doi: 10.1007/s40744-022-00522-0. Epub 2023 Jan 12. Rheumatol Ther. 2023. PMID: 36633815 Free PMC article. Review.
Diagnostic delay in axial spondylarthritis: A lost battle?
Barnett R, Gaffney K, Sengupta R. Barnett R, et al. Among authors: gaffney k. Best Pract Res Clin Rheumatol. 2023 Sep;37(3):101870. doi: 10.1016/j.berh.2023.101870. Epub 2023 Aug 30. Best Pract Res Clin Rheumatol. 2023. PMID: 37658016 Free article. Review.
343 results